Abstract P3-10-16: Competing mortality risks: Cardiovascular risk versus risk of metastatic disease in breast cancer patients receiving adjuvant therapy

MLA

K Nugent, et al. “Abstract P3-10-16: Competing Mortality Risks: Cardiovascular Risk versus Risk of Metastatic Disease in Breast Cancer Patients Receiving Adjuvant Therapy.” Cancer Research, vol. 78, Feb. 2018, pp. P3-10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9ba228103b786abed726ad27d0017a43&authtype=sso&custid=ns315887.

APA

K Nugent, Lisa Mary Prior, M Lim, H Featherstone, & Catherine M. Kelly. (2018). Abstract P3-10-16: Competing mortality risks: Cardiovascular risk versus risk of metastatic disease in breast cancer patients receiving adjuvant therapy. Cancer Research, 78, P3-10.

Chicago

K Nugent, Lisa Mary Prior, M Lim, H Featherstone, and Catherine M. Kelly. 2018. “Abstract P3-10-16: Competing Mortality Risks: Cardiovascular Risk versus Risk of Metastatic Disease in Breast Cancer Patients Receiving Adjuvant Therapy.” Cancer Research 78 (February): P3-10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9ba228103b786abed726ad27d0017a43&authtype=sso&custid=ns315887.